Runzi Sun
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 6
- Cancer Immunotherapy and Biomarkers 6
-
- Liver Diseases and Immunity 1
- Co-authors
- Binfeng Lu (14 shared papers)Jingting Jiang (7 shared papers)Song Li (4 shared papers)Zhuoya Wan (5 shared papers)Jason Shoush (1 shared paper)Lujun Chen (3 shared papers)Yuang Chen (3 shared papers)Ziqian Zhang (3 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (2 papers)Hepatology Communications (2 papers)Science Advances (2 papers)Molecular Therapy — Nucleic Acids (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Runzi Sun
17 papers receiving 532 citations
Peers
Comparison fields: 5 of 36
- Oncology 106
- Biomaterials 54
- Immunology 84
- Cancer Research 16
- Genetics 9
Countries citing papers authored by Runzi Sun
This map shows the geographic impact of Runzi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runzi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runzi Sun more than expected).
Fields of papers citing papers by Runzi Sun
This network shows the impact of papers produced by Runzi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runzi Sun. The network helps show where Runzi Sun may publish in the future.
Co-authors
The 25 scholars most cited alongside Runzi Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 107 | |
| 2 | 2022 | 46 | |
| 3 | 2020 | 44 | |
| 4 | 2021 | 42 | |
| 5 | 2023 | 42 | |
| 6 | 2020 | 40 | |
| 7 | 2022 | 32 | |
| 8 | 2021 | 29 | |
| 9 | 2019 | 27 | |
| 10 | 2021 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2021 | 22 | |
| 13 | 2020 | 19 | |
| 14 | 2021 | 13 | |
| 15 | 2022 | 12 | |
| 16 | 2020 | 10 | |
| 17 | 2023 | 9 |
About Runzi Sun
Runzi Sun is a scholar working on Oncology, Hepatology, Biomaterials, Immunology and Molecular Biology, having authored 17 papers that have together received 540 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), RNA Interference and Gene Delivery (1 paper), Liver Diseases and Immunity (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Oncology (106 citations), Biomaterials (54 citations), Immunology (84 citations), Cancer Research (16 citations) and Genetics (9 citations). Runzi Sun has collaborated with scholars based in United States and China. Frequent co-authors include Binfeng Lu, Jingting Jiang, Song Li, Zhuoya Wan, Jason Shoush, Lujun Chen, Yuang Chen, Ziqian Zhang, Haozhe Huang and Yixian Huang. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Hepatology Communications, Science Advances, Molecular Therapy — Nucleic Acids and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.